[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Low vitamin D and increased deaths", "description": "Lower levels of vitamin D, higher rates of death\n\nAssociation of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Adult Patients With Existing Cardiovascular Disease\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496747/\n\nObservational study, non-interventional\n\nBackground\n\nVitamin D, lower levels, common in patients with cardiovascular disease (CVD)\n\nStudy of patients with existing CVD \n\nProspectively examine the associations of serum 25-hydroxyvitamin D [25(OH)D] concentrations with,\n\nAll-cause mortality and,\n\ncause-specific mortality\n\nMethods\n\nN = 37,079 patients with CVD from the UK \n\nBiobank study\n\nFrom a prospective cohort of half a million, aged 40\u201369 years\n\nhttps://www.ukbiobank.ac.uk\n\nCVD\n\nCoronary heart disease\n\nAtrial fibrillation\n\nHeart failure\n\nStroke\n\nResults\n\nAmong 37,079 patients with CVD at baseline, 57.5% were vitamin D deficient\n\nDeficient, 25[OH]D less than 50 nmol/L (less than 20ng/ml)\n\nMedian follow-up of 11.7 years\n\nDeaths that occurred =  6,319 total \n\n2,161 deaths from CVD\n\n2,230 deaths from cancer\n\n623 deaths from respiratory disease\n\n1,305 other-cause deaths\n\nNon-linear inverse associations\n\nFor all-cause mortality\n\nCancer mortality\n\nRespiratory disease mortality\n\nOther-cause mortality\n\nThat is deaths went up as vitamin D levels went down\n\n(P-non-linearity less than 0.01)\n\nApproximately linear inverse associations for CVD\n\nThat is deaths went up as vitamin D levels went down\n\n(P-non-linearity = 0.074)\n\nAmong CVD patients with vitamin D deficiency\n\nFor every 10 nmol/L increment in serum 25(OH)D concentrations,\n\nThere was an associated 12% reduced risk for all-cause mortality\n\nThere was an associated 9% reduced risk for CVD mortality.\n\nIn patients with vitamin D deficiency\n\nPer 10 nmol/L increase in serum 25(OH)D levels,\n\nwas associated with a lower risk of mortality from (aHR]; 95% CI)\n\nAll-cause 0.88\n\nCVD 0.91\n\nCancer 0.90\n\nRespiratory diseases 0.81\n\nOther causes 0.81\n\nMultivariable Cox regression models\n\nAge, sex, alcohol, BMI, GFR, education, ethnicity, household income, smoking status, healthy diet score, diabetes (and meds), HbA1c, duration of CVD, blood pressure (and meds), lipid profile (and meds), triglycerides, cholesterol\n\nConclusion\n\nAmong patients with existing CVD,\n\nincreasing levels in serum 25(OH)D,\n\nwere independently associated with a decreased risk of all-cause and cause-specific mortality\n\nThese findings suggest that elevated serum 25(OH)D concentration benefits CVD patients with vitamin D deficiency.\n\nTherefore\n\nPatients with vitamin D deficiency may benefit more from an increase in serum levels,\n\nthan those with CVD and serum 25(OH)D levels of less than 50 nmol/L (less than 20ng/ml)\n\nOur findings provided novel clues\nawaiting further validation in clinical trials.", "link": "https://www.youtube.com/watch?v=HwNgKJ-7YWQ", "date_published": "2021-10-27 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]